Clinical trial
A Clinical Safety (Phase II) Increasing Dose Study of MP4 (Hemospan®) in Total Prostatectomy Surgical Patients
NCT00425334 is registered in ClinicalTrials.gov with Sangart as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Clinical Safety (Phase II) Increasing Dose Study of MP4 (Hemospan®) in Total Prostatectomy Surgical Patients
- Lead sponsor
- Sangart
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- July 31, 2005
- Completion date
- November 30, 2007
- Enrollment
- 20 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
blood loss, surgical, prostate cancer, surgery